Click for best price

Active Transdermal Drug Delivery Device Market Size, Share 2022

Market Analysis and Insights: Global Active Transdermal Drug Delivery Device Market

The global Active Transdermal Drug Delivery Device market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Active Transdermal Drug Delivery Device market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Active Transdermal Drug Delivery Device market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Active Transdermal Drug Delivery Device market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Active Transdermal Drug Delivery Device market.

Global Active Transdermal Drug Delivery Device Scope and Market Size

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Patches

Gels

Segment by Application

Clinic

Hospital

Home Use

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

By Company

Novartis AG

Noven Pharmaceuticals, Inc.

Transdermal Corp.

Johnson & Johnson (Janssen Pharmaceuticals Inc.)

Mylan N.V.

Actavis, Inc.

Bayer AG

Boehringer Ingelheim GmbH

Corium International, Inc.

Echo Therapeutics, Inc.

GlaxoSmithKline plc

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Active Transdermal Drug Delivery Device product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Active Transdermal Drug Delivery Device, with price, sales, revenue, and global market share of Active Transdermal Drug Delivery Device from 2019 to 2022.

Chapter 3, the Active Transdermal Drug Delivery Device competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Active Transdermal Drug Delivery Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Active Transdermal Drug Delivery Device market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Active Transdermal Drug Delivery Device.

Chapter 13, 14, and 15, to describe Active Transdermal Drug Delivery Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Active Transdermal Drug Delivery Device Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global Active Transdermal Drug Delivery Device Market Research Report 2022
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2021
Forecast Year	2029
Number of Pages	94 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Active Transdermal Drug Delivery Device Market Overview
1.1 Product Overview and Scope of Active Transdermal Drug Delivery Device
1.2 Active Transdermal Drug Delivery Device Segment by Type
1.2.1 Global Active Transdermal Drug Delivery Device Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Patches
1.2.3 Gels
1.3 Active Transdermal Drug Delivery Device Segment by Application
1.3.1 Global Active Transdermal Drug Delivery Device Sales Comparison by Application: (2022-2028)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home Use
1.4 Global Active Transdermal Drug Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Active Transdermal Drug Delivery Device Revenue 2017-2028
1.4.2 Global Active Transdermal Drug Delivery Device Sales 2017-2028
1.4.3 Active Transdermal Drug Delivery Device Market Size by Region: 2017 Versus 2021 Versus 2028
2 Active Transdermal Drug Delivery Device Market Competition by Manufacturers
2.1 Global Active Transdermal Drug Delivery Device Sales Market Share by Manufacturers (2017-2022)
2.2 Global Active Transdermal Drug Delivery Device Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Active Transdermal Drug Delivery Device Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Active Transdermal Drug Delivery Device Manufacturing Sites, Area Served, Product Type
2.5 Active Transdermal Drug Delivery Device Market Competitive Situation and Trends
2.5.1 Active Transdermal Drug Delivery Device Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Active Transdermal Drug Delivery Device Players Market Share by Revenue
2.5.3 Global Active Transdermal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Active Transdermal Drug Delivery Device Retrospective Market Scenario by Region
3.1 Global Active Transdermal Drug Delivery Device Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Active Transdermal Drug Delivery Device Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Active Transdermal Drug Delivery Device Market Facts & Figures by Country
3.3.1 North America Active Transdermal Drug Delivery Device Sales by Country
3.3.2 North America Active Transdermal Drug Delivery Device Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Active Transdermal Drug Delivery Device Market Facts & Figures by Country
3.4.1 Europe Active Transdermal Drug Delivery Device Sales by Country
3.4.2 Europe Active Transdermal Drug Delivery Device Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Active Transdermal Drug Delivery Device Market Facts & Figures by Region
3.5.1 Asia Pacific Active Transdermal Drug Delivery Device Sales by Region
3.5.2 Asia Pacific Active Transdermal Drug Delivery Device Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Active Transdermal Drug Delivery Device Market Facts & Figures by Country
3.6.1 Latin America Active Transdermal Drug Delivery Device Sales by Country
3.6.2 Latin America Active Transdermal Drug Delivery Device Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Active Transdermal Drug Delivery Device Market Facts & Figures by Country
3.7.1 Middle East and Africa Active Transdermal Drug Delivery Device Sales by Country
3.7.2 Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Active Transdermal Drug Delivery Device Historic Market Analysis by Type
4.1 Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
4.2 Global Active Transdermal Drug Delivery Device Revenue Market Share by Type (2017-2022)
4.3 Global Active Transdermal Drug Delivery Device Price by Type (2017-2022)
5 Global Active Transdermal Drug Delivery Device Historic Market Analysis by Application
5.1 Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
5.2 Global Active Transdermal Drug Delivery Device Revenue Market Share by Application (2017-2022)
5.3 Global Active Transdermal Drug Delivery Device Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Novartis AG Active Transdermal Drug Delivery Device Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Noven Pharmaceuticals, Inc.
6.2.1 Noven Pharmaceuticals, Inc. Corporation Information
6.2.2 Noven Pharmaceuticals, Inc. Description and Business Overview
6.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product Portfolio
6.2.5 Noven Pharmaceuticals, Inc. Recent Developments/Updates
6.3 Transdermal Corp.
6.3.1 Transdermal Corp. Corporation Information
6.3.2 Transdermal Corp. Description and Business Overview
6.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Transdermal Corp. Active Transdermal Drug Delivery Device Product Portfolio
6.3.5 Transdermal Corp. Recent Developments/Updates
6.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
6.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
6.4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
6.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product Portfolio
6.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments/Updates
6.5 Mylan N.V.
6.5.1 Mylan N.V. Corporation Information
6.5.2 Mylan N.V. Description and Business Overview
6.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Mylan N.V. Active Transdermal Drug Delivery Device Product Portfolio
6.5.5 Mylan N.V. Recent Developments/Updates
6.6 3M
6.6.1 3M Corporation Information
6.6.2 3M Description and Business Overview
6.6.3 3M Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.6.4 3M Active Transdermal Drug Delivery Device Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 Actavis, Inc.
6.6.1 Actavis, Inc. Corporation Information
6.6.2 Actavis, Inc. Description and Business Overview
6.6.3 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Actavis, Inc. Active Transdermal Drug Delivery Device Product Portfolio
6.7.5 Actavis, Inc. Recent Developments/Updates
6.8 Bayer AG
6.8.1 Bayer AG Corporation Information
6.8.2 Bayer AG Description and Business Overview
6.8.3 Bayer AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Bayer AG Active Transdermal Drug Delivery Device Product Portfolio
6.8.5 Bayer AG Recent Developments/Updates
6.9 Boehringer Ingelheim GmbH
6.9.1 Boehringer Ingelheim GmbH Corporation Information
6.9.2 Boehringer Ingelheim GmbH Description and Business Overview
6.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product Portfolio
6.9.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.10 Corium International, Inc.
6.10.1 Corium International, Inc. Corporation Information
6.10.2 Corium International, Inc. Description and Business Overview
6.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Corium International, Inc. Active Transdermal Drug Delivery Device Product Portfolio
6.10.5 Corium International, Inc. Recent Developments/Updates
6.11 Echo Therapeutics, Inc.
6.11.1 Echo Therapeutics, Inc. Corporation Information
6.11.2 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Description and Business Overview
6.11.3 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product Portfolio
6.11.5 Echo Therapeutics, Inc. Recent Developments/Updates
6.12 GlaxoSmithKline plc
6.12.1 GlaxoSmithKline plc Corporation Information
6.12.2 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Description and Business Overview
6.12.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.12.4 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product Portfolio
6.12.5 GlaxoSmithKline plc Recent Developments/Updates
7 Active Transdermal Drug Delivery Device Manufacturing Cost Analysis
7.1 Active Transdermal Drug Delivery Device Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Active Transdermal Drug Delivery Device
7.4 Active Transdermal Drug Delivery Device Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Active Transdermal Drug Delivery Device Distributors List
8.3 Active Transdermal Drug Delivery Device Customers
9 Active Transdermal Drug Delivery Device Market Dynamics
9.1 Active Transdermal Drug Delivery Device Industry Trends
9.2 Active Transdermal Drug Delivery Device Market Drivers
9.3 Active Transdermal Drug Delivery Device Market Challenges
9.4 Active Transdermal Drug Delivery Device Market Restraints
10 Global Market Forecast
10.1 Active Transdermal Drug Delivery Device Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Active Transdermal Drug Delivery Device by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Active Transdermal Drug Delivery Device by Type (2023-2028)
10.2 Active Transdermal Drug Delivery Device Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Active Transdermal Drug Delivery Device by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Active Transdermal Drug Delivery Device by Application (2023-2028)
10.3 Active Transdermal Drug Delivery Device Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Active Transdermal Drug Delivery Device by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Active Transdermal Drug Delivery Device by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Active Transdermal Drug Delivery Device Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Active Transdermal Drug Delivery Device Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Active Transdermal Drug Delivery Device Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Active Transdermal Drug Delivery Device Market Competitive Situation by Manufacturers in 2021
Table 5. Global Active Transdermal Drug Delivery Device Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Active Transdermal Drug Delivery Device Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Active Transdermal Drug Delivery Device Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Active Transdermal Drug Delivery Device Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Active Transdermal Drug Delivery Device Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Active Transdermal Drug Delivery Device Manufacturing Sites and Area Served
Table 11. Manufacturers Active Transdermal Drug Delivery Device Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Active Transdermal Drug Delivery Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Transdermal Drug Delivery Device as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Active Transdermal Drug Delivery Device Sales by Region (2017-2022) & (K Units)
Table 16. Global Active Transdermal Drug Delivery Device Sales Market Share by Region (2017-2022)
Table 17. Global Active Transdermal Drug Delivery Device Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Active Transdermal Drug Delivery Device Revenue Market Share by Region (2017-2022)
Table 19. North America Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
Table 20. North America Active Transdermal Drug Delivery Device Sales Market Share by Country (2017-2022)
Table 21. North America Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Active Transdermal Drug Delivery Device Revenue Market Share by Country (2017-2022)
Table 23. Europe Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
Table 24. Europe Active Transdermal Drug Delivery Device Sales Market Share by Country (2017-2022)
Table 25. Europe Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Active Transdermal Drug Delivery Device Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Active Transdermal Drug Delivery Device Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Active Transdermal Drug Delivery Device Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Active Transdermal Drug Delivery Device Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Active Transdermal Drug Delivery Device Revenue Market Share by Region (2017-2022)
Table 31. Latin America Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Active Transdermal Drug Delivery Device Sales Market Share by Country (2017-2022)
Table 33. Latin America Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Active Transdermal Drug Delivery Device Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Active Transdermal Drug Delivery Device Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Active Transdermal Drug Delivery Device Revenue Market Share by Country (2017-2022)
Table 39. Global Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 40. Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 41. Global Active Transdermal Drug Delivery Device Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Active Transdermal Drug Delivery Device Revenue Share by Type (2017-2022)
Table 43. Global Active Transdermal Drug Delivery Device Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Active Transdermal Drug Delivery Device Sales (K Units) by Application (2017-2022)
Table 45. Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 46. Global Active Transdermal Drug Delivery Device Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Active Transdermal Drug Delivery Device Revenue Share by Application (2017-2022)
Table 48. Global Active Transdermal Drug Delivery Device Price by Application (2017-2022) & (USD/Unit)
Table 49. Novartis AG Corporation Information
Table 50. Novartis AG Description and Business Overview
Table 51. Novartis AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Novartis AG Active Transdermal Drug Delivery Device Product
Table 53. Novartis AG Recent Developments/Updates
Table 54. Noven Pharmaceuticals, Inc. Corporation Information
Table 55. Noven Pharmaceuticals, Inc. Description and Business Overview
Table 56. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product
Table 58. Noven Pharmaceuticals, Inc. Recent Developments/Updates
Table 59. Transdermal Corp. Corporation Information
Table 60. Transdermal Corp. Description and Business Overview
Table 61. Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Transdermal Corp. Active Transdermal Drug Delivery Device Product
Table 63. Transdermal Corp. Recent Developments/Updates
Table 64. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
Table 65. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
Table 66. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product
Table 68. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments/Updates
Table 69. Mylan N.V. Corporation Information
Table 70. Mylan N.V. Description and Business Overview
Table 71. Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Mylan N.V. Active Transdermal Drug Delivery Device Product
Table 73. Mylan N.V. Recent Developments/Updates
Table 74. 3M Corporation Information
Table 75. 3M Description and Business Overview
Table 76. 3M Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. 3M Active Transdermal Drug Delivery Device Product
Table 78. 3M Recent Developments/Updates
Table 79. Actavis, Inc. Corporation Information
Table 80. Actavis, Inc. Description and Business Overview
Table 81. Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Actavis, Inc. Active Transdermal Drug Delivery Device Product
Table 83. Actavis, Inc. Recent Developments/Updates
Table 84. Bayer AG Corporation Information
Table 85. Bayer AG Description and Business Overview
Table 86. Bayer AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Bayer AG Active Transdermal Drug Delivery Device Product
Table 88. Bayer AG Recent Developments/Updates
Table 89. Boehringer Ingelheim GmbH Corporation Information
Table 90. Boehringer Ingelheim GmbH Description and Business Overview
Table 91. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product
Table 93. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 94. Corium International, Inc. Corporation Information
Table 95. Corium International, Inc. Description and Business Overview
Table 96. Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Corium International, Inc. Active Transdermal Drug Delivery Device Product
Table 98. Corium International, Inc. Recent Developments/Updates
Table 99. Echo Therapeutics, Inc. Corporation Information
Table 100. Echo Therapeutics, Inc. Description and Business Overview
Table 101. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product
Table 103. Echo Therapeutics, Inc. Recent Developments/Updates
Table 104. GlaxoSmithKline plc Corporation Information
Table 105. GlaxoSmithKline plc Description and Business Overview
Table 106. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product
Table 108. GlaxoSmithKline plc Recent Developments/Updates
Table 109. Production Base and Market Concentration Rate of Raw Material
Table 110. Key Suppliers of Raw Materials
Table 111. Active Transdermal Drug Delivery Device Distributors List
Table 112. Active Transdermal Drug Delivery Device Customers List
Table 113. Active Transdermal Drug Delivery Device Market Trends
Table 114. Active Transdermal Drug Delivery Device Market Drivers
Table 115. Active Transdermal Drug Delivery Device Market Challenges
Table 116. Active Transdermal Drug Delivery Device Market Restraints
Table 117. Global Active Transdermal Drug Delivery Device Sales Forecast by Type (2023-2028) & (K Units)
Table 118. Global Active Transdermal Drug Delivery Device Sales Market Share Forecast by Type (2023-2028)
Table 119. Global Active Transdermal Drug Delivery Device Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Type (2023-2028)
Table 121. Global Active Transdermal Drug Delivery Device Sales Forecast by Application (2023-2028) & (K Units)
Table 122. Global Active Transdermal Drug Delivery Device Sales Market Share Forecast by Application (2023-2028)
Table 123. Global Active Transdermal Drug Delivery Device Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 124. Global Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Application (2023-2028)
Table 125. Global Active Transdermal Drug Delivery Device Sales Forecast by Region (2023-2028) & (K Units)
Table 126. Global Active Transdermal Drug Delivery Device Sales Market Share Forecast by Region (2023-2028)
Table 127. Global Active Transdermal Drug Delivery Device Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 128. Global Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Region (2023-2028)
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Active Transdermal Drug Delivery Device
Figure 2. Global Active Transdermal Drug Delivery Device Market Share by Type in 2021 & 2028
Figure 3. Patches Product Picture
Figure 4. Gels Product Picture
Figure 5. Global Active Transdermal Drug Delivery Device Market Share by Application in 2021 & 2028
Figure 6. Clinic
Figure 7. Hospital
Figure 8. Home Use
Figure 9. Global Active Transdermal Drug Delivery Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Active Transdermal Drug Delivery Device Market Size (2017-2028) & (US$ Million)
Figure 11. Global Active Transdermal Drug Delivery Device Sales (2017-2028) & (K Units)
Figure 12. Active Transdermal Drug Delivery Device Sales Share by Manufacturers in 2021
Figure 13. Global Active Transdermal Drug Delivery Device Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Active Transdermal Drug Delivery Device Players: Market Share by Revenue in 2021
Figure 15. Active Transdermal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Active Transdermal Drug Delivery Device Sales Market Share by Region (2017-2022)
Figure 17. Global Active Transdermal Drug Delivery Device Sales Market Share by Region in 2021
Figure 18. Global Active Transdermal Drug Delivery Device Revenue Market Share by Region (2017-2022)
Figure 19. Global Active Transdermal Drug Delivery Device Revenue Market Share by Region in 2021
Figure 20. U.S. Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Taiwan Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Philippines Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Vietnam Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Active Transdermal Drug Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Active Transdermal Drug Delivery Device by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Active Transdermal Drug Delivery Device
Figure 46. Manufacturing Process Analysis of Active Transdermal Drug Delivery Device
Figure 47. Active Transdermal Drug Delivery Device Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Active Transdermal Drug Delivery Device Market Research Report 2022